Patent ID: 9687514
Date: 2017-06-27
CPC Classifications: A61K,A61P,C07K,C12N

Claim:
1. A panel of isolated bacteriophages for treating a Pseudomonas aeruginosa bacterial infection, wherein the panel comprises two or more bacteriophages selected from the group consisting of: (i) mutants of deposited strains NCIMB 41174, NCIMB 41175, NCIMB 41176, NCIMB 41177, NCIMB 41178, NCIMB 41179, NCIMB 41180, and NCIMB 41181 that retain the ability to infect wherein the mutant has at least 90% nucleotide sequence identity across its whole genome as compared to the genome of the deposited strain, and each member of the panel has a different strain specificity for